Adaptin Bio, Inc. (APTN) Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits

Adaptin Bio, Inc. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits

Adaptin Bio, Inc. (APTN) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits of $6.88 thousand as of 2023-12-31, per its 10-K filed 2025-04-15.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits

us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits · last filed 2025-04-15

• 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits $6.88K.